Ping Xu

Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

Michael J. Haller, Desmond Schatz, Jeffrey P. Krischer et al. · Diabetes Care · 2018 · 180 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Overexpression of the AP2/EREBP transcription factor OPBP1 enhances disease resistance and salt tolerance in tobacco

Zejian Guo, Xujun Chen, Xuelong Wu et al. · Plant Molecular Biology · 2004 · 174 citations

Agriculture, Genetics, Plant Biology +16

Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models

Ran Wei, Limin Mao, Ping Xu et al. · Food & Function · 2018 · 165 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Adsorption of methylene blue onto activated carbon produced from tea (Camellia sinensis L.) seed shells: kinetics, equilibrium, and thermodynamics studies

Junjie Gao, Ye-bo Qin, Tao Zhou et al. · Journal of Zhejiang University SCIENCE B · 2013 · 136 citations · Full text

Engineering, Chemical Engineering, Chemistry +13

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

Michael J. Haller, S. Alice Long, J. Lori Blanchfield et al. · Diabetes · 2019 · 131 citations · Full text

Medicine, Endocrinology, Immunology +17